Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
about
Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkersBiomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis.
P2860
Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Cc-chemokine eotaxin as a mark ...... allergic rhinoconjunctivitis.
@en
Cc-chemokine eotaxin as a mark ...... allergic rhinoconjunctivitis.
@nl
type
label
Cc-chemokine eotaxin as a mark ...... allergic rhinoconjunctivitis.
@en
Cc-chemokine eotaxin as a mark ...... allergic rhinoconjunctivitis.
@nl
prefLabel
Cc-chemokine eotaxin as a mark ...... allergic rhinoconjunctivitis.
@en
Cc-chemokine eotaxin as a mark ...... allergic rhinoconjunctivitis.
@nl
P2860
P1433
P1476
Cc-chemokine eotaxin as a mark ...... d allergic rhinoconjunctivitis
@en
P2093
E Głodzinska-Wyszogrodzka
P2860
P304
P356
10.1034/J.1398-9995.2003.00083.X
P577
2003-07-01T00:00:00Z